• 1. Guizhou Medical University, Guiyang, 550004, P.R.China;
  • 2. Department of Cardiac Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, P.R.China;
YANG Siyuan, Email: 15772955@qq.com
Export PDF Favorites Scan Get Citation

Objective  To evaluate the efficacy and safety of transthoracic minimally invasive occlusion operation for the treatment of congenital atrial and ventricular septal defects. Methods  The clinical data of 88 patients who underwent surgical occlusion operation from December 2015 to February 2017 were summarized. There were 52 males and 36 females, aged 6.8±7.5 years ranging from 1.6 to 24.0 years. All the patients were followed up by ultrasound and electrocardiogram at postoperative 3, 6 and 12 months. The efficacy of minimally invasive thoracotomy was analyzed by statistical methods. Results  The patients were followed up for 3-15 (6.8±2.3) months, and the follow-up rate was 92.0%. Ultrasound showed occluder fixed well and no residual shunt, valve regurgitation, thrombosis or other complications occurred. The heart was reduced, the ejection fraction was greater than 55%, and heart function rating for all patients was grade Ⅰ. Conclusion  Transthoracic mini-invasive surgical occlusion of atrial and ventricular septal defects is safe and effective. The short and middle-term effect is satisfying. It can be widely used in clinical, but multi-center and long-term follow-up and assessment still need to be carried out.

Citation: MENG Xiongwei, YANG Siyuan, HU Xuanyi, JIANG Tian. Efficacy of minimally invasive transthoracic closure of atrial and ventricular septal defects. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2018, 25(8): 715-718. doi: 10.7507/1007-4848.201708049 Copy

  • Previous Article

    Incidence and possible risk factors of chronic postsurgical pain after cardiac surgery: A prospective cohort study
  • Next Article

    Current research on the influence of genetic factors on warfarin maintenance dose